These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 12964883)
41. The laulimalide family: total synthesis and biological evaluation of neolaulimalide, isolaulimalide, laulimalide and a nonnatural analogue. Gollner A; Altmann KH; Gertsch J; Mulzer J Chemistry; 2009 Jun; 15(24):5979-97. PubMed ID: 19402092 [TBL] [Abstract][Full Text] [Related]
42. Tumor cells resistant to a microtubule-depolymerizing hemiasterlin analogue, HTI-286, have mutations in alpha- or beta-tubulin and increased microtubule stability. Poruchynsky MS; Kim JH; Nogales E; Annable T; Loganzo F; Greenberger LM; Sackett DL; Fojo T Biochemistry; 2004 Nov; 43(44):13944-54. PubMed ID: 15518543 [TBL] [Abstract][Full Text] [Related]
43. [High dose chemotherapy in ovarian and breast adenocarcinoma with poor prognosis]. Lotz JP; Gligorov J; Selle F; Lefevre G; Pautier P; Lhommé C Gynecol Obstet Fertil; 2000 Sep; 28(9):620-31. PubMed ID: 11075500 [No Abstract] [Full Text] [Related]
44. Synthesis of potent taxoids for tumor-specific delivery using monoclonal antibodies. Miller ML; Roller EE; Wu X; Leece BA; Goldmacher VS; Chari RV; Ojima I Bioorg Med Chem Lett; 2004 Aug; 14(15):4079-82. PubMed ID: 15225730 [TBL] [Abstract][Full Text] [Related]
45. Laulimalide induces dose-dependent modulation of microtubule behaviour in the C. elegans embryo. Bajaj M; Srayko M PLoS One; 2013; 8(8):e71889. PubMed ID: 23936530 [TBL] [Abstract][Full Text] [Related]
46. Acquired resistance to peloruside A and laulimalide is associated with downregulation of vimentin in human ovarian carcinoma cells. Kanakkanthara A; Rawson P; Northcote PT; Miller JH Pharm Res; 2012 Nov; 29(11):3022-32. PubMed ID: 22584948 [TBL] [Abstract][Full Text] [Related]
47. Synthesis and immunofluorescence assay of a new biotinylated paclitaxel. Sambaiah T; King KY; Tsay SC; Mei NW; Hakimclahi S; Lai YK; Lieu CH; Hwu JR Eur J Med Chem; 2002 Apr; 37(4):349-53. PubMed ID: 11960670 [TBL] [Abstract][Full Text] [Related]
48. Preclinical discovery of ixabepilone, a highly active antineoplastic agent. Lee FY; Borzilleri R; Fairchild CR; Kamath A; Smykla R; Kramer R; Vite G Cancer Chemother Pharmacol; 2008 Dec; 63(1):157-66. PubMed ID: 18347795 [TBL] [Abstract][Full Text] [Related]
49. Synthesis and biological evaluation of (-)-16-normethyldictyostatin: a potent analogue of (-)-dictyostatin. Shin Y; Fournier JH; Balachandran R; Madiraju C; Raccor BS; Zhu G; Edler MC; Hamel E; Day BW; Curran DP Org Lett; 2005 Jul; 7(14):2873-6. PubMed ID: 15987158 [TBL] [Abstract][Full Text] [Related]
50. Potent inhibition of tubulin polymerisation and proliferation of paclitaxel-resistant 1A9PTX22 human ovarian cancer cells by albendazole. Chu SW; Badar S; Morris DL; Pourgholami MH Anticancer Res; 2009 Oct; 29(10):3791-6. PubMed ID: 19846910 [TBL] [Abstract][Full Text] [Related]
51. Synthesis and evaluation of [14C]-labelled and fluorescent-tagged paclitaxel derivatives as new biological probes. Rao CS; Chu JJ; Liu RS; Lai YK Bioorg Med Chem; 1998 Nov; 6(11):2193-204. PubMed ID: 9881110 [TBL] [Abstract][Full Text] [Related]
52. Synthesis of novel 11-desmethyl analogues of laulimalide by Nozaki-Kishi coupling. Paterson I; Bergmann H; Menche D; Berkessel A Org Lett; 2004 Apr; 6(8):1293-5. PubMed ID: 15070320 [TBL] [Abstract][Full Text] [Related]
53. Therapeutic cure against human tumor xenografts in nude mice by a microtubule stabilization agent, fludelone, via parenteral or oral route. Chou TC; Dong H; Zhang X; Tong WP; Danishefsky SJ Cancer Res; 2005 Oct; 65(20):9445-54. PubMed ID: 16230408 [TBL] [Abstract][Full Text] [Related]
54. Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives. Bisi A; Meli M; Gobbi S; Rampa A; Tolomeo M; Dusonchet L Bioorg Med Chem; 2008 Jul; 16(13):6474-82. PubMed ID: 18522868 [TBL] [Abstract][Full Text] [Related]
55. Unsaturated genistein disaccharide glycoside as a novel agent affecting microtubules. Rusin A; Gogler A; Głowala-Kosińska M; Bochenek D; Gruca A; Grynkiewicz G; Zawisza J; Szeja W; Krawczyk Z Bioorg Med Chem Lett; 2009 Sep; 19(17):4939-43. PubMed ID: 19660945 [TBL] [Abstract][Full Text] [Related]
56. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy. Alaoui AE; Saha N; Schmidt F; Monneret C; Florent JC Bioorg Med Chem; 2006 Jul; 14(14):5012-9. PubMed ID: 16554162 [TBL] [Abstract][Full Text] [Related]
57. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin. Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583 [TBL] [Abstract][Full Text] [Related]